BBC icon

Virtus LifeSci Biotech Clinical Trials ETF
BBC

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $3.08M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$351K
2
+$2.71K
3
+$1.23K

Top Sellers

1
-$228K
2
-$153K
3
-$2.18K
4
GRP
Global Retirement Partners
California
-$1.11K
5
Comerica Bank
Comerica Bank
Texas
-$884
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.29M
2
$968K
3
$368K
4
$358K
5
$27.9K
6
$23.4K
7
$22K
8
$12.5K
9
$6.48K
10
$2.79K
11
$1.23K
12
$280
13
$140
14
–
15
–